Incumbents, values and the full list are on Pro
The five rows below show the dates and agencies. Pro ($39/mo) shows every expiring award with the incumbent name, so you can start teaming conversations a year out.
See plans| Ends | Incumbent · description | Agency · office | NAICS · PSC | Value | Set-aside | Source |
|---|---|---|---|---|---|---|
| Sep 15, 2027 | ProADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2) | National Institutes of HealthNIH NCI | 541715 · AN12 | $37M | USAspending | |
| Sep 15, 2027 | ProEMERGING INFECTIOUS DISEASES RESEARCH PREVAIL I, III, V AND PREVAC MALI | National Institutes of HealthNIH NCI | 541715 · AN12 | $5.2M | USAspending | |
| Sep 20, 2027 | ProNCI-ARCDCTD-26-0055 - CPTAC BIOSPECIMEN ACQUISITION, PROCESSING, AND DISTRIBUTION | National Institutes of Health | 5417 · AN12 | $4.5M | USAspending | |
| Sep 1, 2027 | ProNIAID / CHILDRENS NATIONAL MEDICAL CENTER JOINT CLINICAL RESEARCH PROGRAM (JCRP) IMMUNOLOGIC AND INFECTIOUS DISEASES CLI | National Institutes of HealthNIH NCI | 541715 · AN12 | $4.3M | USAspending | |
| Apr 27, 2027 | ProFY232 FACILITIES TO G-B1073 MOLD REMEDIATION | National Institutes of HealthNIH NCI | 541715 · AN12 | $3.8M | USAspending |
Source: USAspending.gov contract awards synced nightly. "Ends" is the current period-of-performance end; an exercised option moves it. Not every expiring award is recompeted.